Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02729415 · ClinicalTrials.gov registry record · NA
Point-of-Care Adipose-derived Cells for Hair Growth
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02729415: Completed NA study, sponsored by University of Florida.
NCT02729415 is a NA study that has completed, run by University of Florida. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02729415, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
Androgenetic alopecia (AGA) is the most common form of hair loss and affects 50% and 23% of Caucasian men and women, respectively, over the age of 50. The percentage of men and women affected over the age of 70 increases to 80% and 60% of Caucasian men and women, respectively. Although alopecia is considered a minor dermatologic condition, it is seen as a serious condition with major life consequences by those with alopecia and has been associated with increased incidence of myocardial infarction, hypertension and hypercholesterolaemia. Androgenetic alopecia is associated with feelings of anxiety, depression and various personality disorders among men and women due to physical appearance. Depression, anxiety, aggressiveness, impaired quality of life and social inadequacy have been documented. The presence of alopecia in women is particularly stressful. ADSCs (Adipose Derived Stromal Cells), also called Stromal Vascular Fraction (SVF) cells, include regenerative cell populations derived from adipose tissue and thus are potentially important to multiple disease processes and therapeutic applications for the repair and regeneration of acute and chronically damaged tissues. It has been postulated that SVF cells may promote hair regeneration by increasing the hair-inducing ability of dermal papillae (DP) cells. The general objective of this study is to conduct a safety and feasibility study of a single injection of autologous adipose-derived SVF cells for the treatment of alopecia.
Primary Outcome
Adverse events will be recorded and evaluated.
Interventions
- PROCEDURE Liposuction
- PROCEDURE Stromal Vascular Fraction Cells (SVF Cells) Injection
- OTHER Hair Measurements
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2016-10 |
| Est. Completion | 2019-01-31 |
| Phase | NA |
What the finished NCT02729415 record still lists
NCT02729415 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Liposuction is the first listed.
NCT02729415 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02729415 about?
NCT02729415 is a clinical study titled "Point-of-Care Adipose-derived Cells for Hair Growth". Androgenetic alopecia (AGA) is the most common form of hair loss and affects 50% and 23% of Caucasian men and women, respectively, over the age of 50. The percentage of men and women affected over the age of 70 increases to 80% and 60% of Caucasian men and women, respectively. Although alopecia is c...
What is the current status of trial NCT02729415?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2016-10. Estimated completion is 2019-01-31.
What interventions are being tested in trial NCT02729415?
The interventions under investigation include: Liposuction (PROCEDURE), Stromal Vascular Fraction Cells (SVF Cells) Injection (PROCEDURE), Hair Measurements (OTHER).
Who is sponsoring clinical trial NCT02729415?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02729415's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia